Result of interrupted time-series analyses† for eight MCH utilisation indicators
| Indicator | Pre-pandemic (January 2019–February 2020) | Level change after first lockdown implementation (March 2020) | Trend after first lockdown implementation (March–May 2020) | Level change after lifting of first lockdown (June 2020) | Trend after lifting of first lockdown (June–December 2020) | Level change after second lockdown implementation (January 2021) | Trend after second lockdown implementation (January–June 2021) |
| Coeff (95% CI) | Coeff (95% CI) | Coeff (95% CI) | Coeff (95% CI) | Coeff (95% CI) | Coeff (95% CI) | Coeff (95% CI) | |
| ANC | 0.31% (−0.20% to 0.81%) | −4.11% (−8.27% to 0.23%) | −8.10% (−8.30% to −7.91%)*** | 29.12% (24.83% to 33.55%)*** | −0.28% (−1.19% to 0.63%) | −4.06% (−10.49% to 2.82%) | 1.14% (−0.20% to 2.50%) |
| PNC | −1.43% (−1.98% to −0.88%)*** | 6.50% (3.15% to 9.96%)*** | −4.85% (−5.04% to −4.66%)*** | 18.09% (0.11% to 39.29%)* | −1.41% (−4.87% to 2.18%) | −13.08 (−21.85% to −3.34%)* | 1.92% (1.14% to 2.70%) |
| PNC 1 week | 0.35% (−0.68% to 1.40%) | −4.66% (−13.67% to 5.29%) | −3.52% (−3.55% to −3.48%)*** | 17.59% (16.56% to 18.64%)*** | 0.68% (0.48% to 0.88%)*** | −25.92% (−30.62% to −20.91%)*** | 3.83% (1.52% to 6.19%)** |
| Women’s health‡ | 0.19% (−0.63% to 1.02%) | −8.05% (−16.96% to 1.82%) | −10.12% (−13.83% to −6.25%)*** | 27.70% (15.47% to 41.23%)*** | 1.25% (0.48% to 2.02%)** | −11.29% (−16.98% to −5.21%)** | 0.48% (−1.34% to 2.32%) |
| Contraception | 0.66% (0.19% to 1.13%)** | 0.64% (−4.79% to 6.38%) | −6.50% (−9.24% to −3.69%)*** | 12.62% (3.23% to 22.86%)** | 0.67% (−0.77% to 2.13%) | −21.69% (−29.76% to −12.69%)*** | 1.21% (−0.33% to 2.78%) |
| Child health | 0.45% (−0.29% to 1.19%) | −16.91% (−30.72% to −0.35%)* | −19.23% (−29.63% to −7.30%)** | 62.01% (19.02% to 120.53%)** | 2.64% (1.55% to 3.74%)*** | −11.95% (−18.82% to −4.50%)** | 1.44% (−0.01% to 2.92%) |
| DTaP‡ | −0.14% (−0.88% to 0.61%) | 1.49% (−9.63% to 13.97%) | −1.78% (−6.84% to 3.55%) | 6.36% (−6.80% to 21.38%) | −0.18% (−2.93% to 2.66%) | −8.77% (−21.06% to 5.43%) | 2.61% (−0.10% to 5.39%) |
| MMR‡ | −0.01% (−0.45% to 0.44%) | −1.99% (−9.89% to 6.60%) | −0.28% (−4.28% to 3.88%) | 8.80% (−0.22% to 18.63%) | −0.01% (−2.41% to 2.45%) | −9.50% (−21.15% to 3.88%) | 2.42% (0.14% to 4.75%)* |
Statistical significance was indicated by *0.01≤p<0.05, **0.001≤p<0.01, ***p<0.001.
†Performed using ordinary least square regression method with Newey-West SE except otherwise indicated.
‡Performed using generalised least square regression.
ANC, antenatal care clinic attendance; Child health, child health clinic attendance; Contraception, number of women receiving oral or injectable contraception; DTaP, number of diphtheria, tetanus and pertussis (booster) injection given; MMR, number of first dose measles, mumps and rubella injection given to child age less than 1 year; PNC, postnatal care clinic attendance; PNC 1 week, number of postnatal mothers with at least two visits within 7 days of delivery; Women health, women’s health clinic attendance.